Abdallah, Zeina
Boucher, Yann G.
Fernandez, Arnaud
Balac, Stéphane
Llopis, Olivier
Article History
Received: 21 January 2016
Accepted: 11 May 2016
First Online: 2 June 2016
Competing interests
: M.A.F.K. is the founder of Vaxxas Pty Ltd, a company developing the Nanopatch for drug delivery applications. M.L.C., A.C.I.D. and M.A.F.K. are inventors on several patents (including work that is included in this paper) currently licensed by Vaxxas. The remaining authors state no conflict.